Genetic variation in the TNF receptor-associated factor 6 gene is associated with susceptibility to sepsis-induced acute lung injury

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Song, Zhenju ^a   Yao, Chenling ^a   Yin, Jun ^a   Tong, Chaoyang ^a   Zhu, Duming ^a   Sun, Zhan ^a   Jiang, Jinjun ^a   Shao, Mian ^a   Zhang, Yaping ^a   Deng, Zhi ^a   Tao, Zhengang ^a   Sun, Si ^a   Bai, Chunxue ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute lung injury; Genetic variation; TLR signaling pathway; TRAF6

Indexed keywords

INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 6; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ACUTE LUNG INJURY; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; IRAK1 GENE; IRAK4 GENE; MAJOR CLINICAL STUDY; MALE; MYD88 GENE; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRAF6 GENE;

ACUTE LUNG INJURY; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VARIATION; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SEPSIS; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84865054140     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-166     Document Type: Article

References (44)

1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693. 10.1056/NEJMoa050333, 16236739.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349. 10.1056/NEJM200005043421806, 10793167.
3. Gao L, Barnes KC. Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol 2009, 296:L713-L725. 10.1152/ajplung.90269.2008, 2681344, 19218355.
4. Villar J, Flores C, Mendez-Alvarez S. Genetic susceptibility to acute lung injury. Crit Care Med 2003, 31:S272-S275. 10.1097/01.CCM.0000057903.11528.6D, 12682452.
5. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, Boyce P, Christiani DC. 308GA and TNFB polymorphisms in acute respiratory distress syndrome. Eur Respir J 2005, 26:382-389. 10.1183/09031936.05.00000505, 16135717.
6. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, Kleeberger SR. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007, 21:2237-2246. 10.1096/fj.06-7759com, 17384144.
7. Su L, Zhai R, Sheu CC, Gallagher DC, Gong MN, Tejera P, Thompson BT, Christiani DC. Genetic variants in the angiopoietin-2 gene are associated with increased risk of ARDS. Intensive Care Med 2009, 35:1024-1030. 10.1007/s00134-009-1413-8, 2696283, 19271210.
8. Zhai R, Zhou W, Gong MN, Thompson BT, Su L, Yu C, Kraft P, Christiani DC. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit Care Med 2007, 35:893-898. 10.1097/01.CCM.0000256845.92640.38, 17235259.
9. Gao L, Grant A, Halder I, Brower R, Sevransky J, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, et al. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury. Am J Respir Cell Mol Biol 2006, 34:487-495. 10.1165/rcmb.2005-0404OC, 2644210, 16399953.
10. Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006, 34:1001-1006. 10.1097/01.CCM.0000206107.92476.39, 16484896.
11. Bajwa EK, Cremer PC, Gong MN, Zhai R, Su L, Thompson BT, Christiani DC. An NFKB1 promoter insertion/deletion polymorphism influences risk and outcome in acute respiratory distress syndrome among Caucasians. PLoS One 2011, 6:e19469. 10.1371/journal.pone.0019469, 3090449, 21573030.
12. Ma SF, Xie L, Pino-Yanes M, Sammani S, Wade MS, Letsiou E, Siegler J, Wang T, Infusino G, Kittles RA, et al. Type 2 deiodinase and host responses of sepsis and acute lung injury. Am J Respir Cell Mol Biol 2011, 45:1203-1211. 10.1165/rcmb.2011-0179OC, 21685153.
13. Pino-Yanes M, Ma SF, Sun X, Tejera P, Corrales A, Blanco J, Perez-Mendez L, Espinosa E, Muriel A, Blanch L, et al. Interleukin-1 receptor-associated kinase 3 gene associates with susceptibility to acute lung injury. Am J Respir Cell Mol Biol 2011, 45:740-745. 10.1165/rcmb.2010-0292OC, 3265218, 21297081.
14. Meyer NJ, Li M, Feng R, Bradfield J, Gallop R, Bellamy S, Fuchs BD, Lanken PN, Albelda SM, Rushefski M, et al. ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med 2011, 183:1344-1353. 10.1164/rccm.201005-0701OC, 3114062, 21257790.
15. Glavan BJ, Holden TD, Goss CH, Black RA, Neff MJ, Nathens AB, Martin TR, Wurfel MM. Genetic variation in the FAS gene and associations with acute lung injury. Am J Respir Crit Care Med 2011, 183:356-363. 10.1164/rccm.201003-0351OC, 3056231, 20813889.
16. Arcaroli JJ, Hokanson JE, Abraham E, Geraci M, Murphy JR, Bowler RP, Dinarello CA, Silveira L, Sankoff J, Heyland D, et al. Extracellular superoxide dismutase haplotypes are associated with acute lung injury and mortality. Am J Respir Crit Care Med 2009, 179:105-112. 2633057, 18948423.
17. Arcaroli JJ, Liu N, Yi N, Abraham E. Association between IL-32 genotypes and outcome in infection-associated acute lung injury. Crit Care 2011, 15:R138. 10.1186/cc10258, 3219007, 21649914.
18. Flores C, Pino-Yanes Mdel M, Villar J. A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 2008, 12:R130. 10.1186/cc7098, 2592769, 18950526.
19. Grigoryev DN, Finigan JH, Hassoun P, Garcia JG. Science review: searching for gene candidates in acute lung injury. Crit Care 2004, 8:440-447. 10.1186/cc2901, 1065043, 15566614.
20. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4:499-511. 10.1038/nri1391, 15229469.
21. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11:115-122. 10.1016/S1074-7613(00)80086-2, 10435584.
22. Swantek JL, Tsen MF, Cobb MH, Thomas JA. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J Immunol 2000, 164:4301-4306.
23. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002, 416:750-756. 10.1038/nature736, 11923871.
24. Liu S, Lutz J, Chang J, Liu D, Heemann U, Baumann M. TRAF6 knockdown promotes survival and inhibits inflammatory response to lipopolysaccharides in rat primary renal proximal tubule cells. Acta Physiol (Oxf) 2010, 199:339-346.
25. Jiang D, Liang J, Li Y, Noble PW. The role of Toll-like receptors in non-infectious lung injury. Cell Res 2006, 16:693-701. 10.1038/sj.cr.7310085, 16894359.
26. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249. 10.1016/j.cell.2008.02.043, 18423196.
27. Kumpf O, Giamarellos-Bourboulis EJ, Koch A, Hamann L, Mouktaroudi M, Oh DY, Latz E, Lorenz E, Schwartz DA, Ferwerda B, et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts. Crit Care 2010, 14:R103. 10.1186/cc9047, 2911747, 20525286.
28. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, Kajikawa O, Ruzinski JT, Rona G, Black RA, Stratton S, et al. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 2008, 178:710-720. 10.1164/rccm.200803-462OC, 2556453, 18635889.
29. Pino-Yanes M, Corrales A, Casula M, Blanco J, Muriel A, Espinosa E, Garcia-Bello M, Torres A, Ferrer M, Zavala E, et al. Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis. PLoS One 2010, 5:e13759. 10.1371/journal.pone.0013759, 2966434, 21048935.
30. Toubiana J, Courtine E, Pene F, Viallon V, Asfar P, Daubin C, Rousseau C, Chenot C, Ouaaz F, Grimaldi D, et al. IRAK1 functional genetic variant affects severity of septic shock. Crit Care Med 2010, 38:2287-2294. 10.1097/CCM.0b013e3181f9f9c7, 20890200.
31. Arcaroli J, Silva E, Maloney JP, He Q, Svetkauskaite D, Murphy JR, Abraham E. Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 2006, 173:1335-1341. 10.1164/rccm.200603-341OC, 2662973, 16528020.
32. Ferwerda B, Alonso S, Banahan K, McCall MB, Giamarellos-Bourboulis EJ, Ramakers BP, Mouktaroudi M, Fain PR, Izagirre N, Syafruddin D, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc Natl Acad Sci U S A 2009, 106:10272-10277. 10.1073/pnas.0811273106, 2700915, 19509334.
33. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, Ling EY, Frodsham AJ, Walley AJ, Kyrieleis O, Khan A, et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat Genet 2007, 39:523-528. 10.1038/ng1976, 2660299, 17322885.
34. Song Z, Tong C, Sun Z, Shen Y, Yao C, Jiang J, Yin J, Gao L, Song Y, Bai C. Genetic variants in the TIRAP gene are associated with increased risk of sepsis-associated acute lung injury. BMC Med Genet 2010, 11:168. 10.1186/1471-2350-11-168, 3001691, 21118491.
35. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874. 10.1097/00003246-199206000-00025, 1597042, American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference.
36. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. The Consensus Committee. Intensive Care Med 1994, 20:225-232. 10.1007/BF01704707, 8014293.
37. Chen J, Zheng H, Bei JX, Sun L, Jia WH, Li T, Zhang F, Seielstad M, Zeng YX, Zhang X, Liu J. Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 2009, 85:775-785. 10.1016/j.ajhg.2009.10.016, 2790583, 19944401.
38. Xu S, Yin X, Li S, Jin W, Lou H, Yang L, Gong X, Wang H, Shen Y, Pan X, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet 2009, 85:762-774. 10.1016/j.ajhg.2009.10.015, 2790582, 19944404.
39. Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, Haynes RB, Henderson BE, Kaaks R, Stram DO, et al. A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer 2005, 5:977-985. 10.1038/nrc1754, 16341085.
40. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
41. Murray LA, Knight DA, McAlonan L, Argentieri R, Joshi A, Shaheen F, Cunningham M, Alexopolou L, Flavell RA, Sarisky RT, Hogaboam CM. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2008, 178:1227-1237. 10.1164/rccm.200807-1020OC, 18849495.
42. Gohda J, Matsumura T, Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling. J Immunol 2004, 173:2913-2917.
43. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, De Kimpe SJ, Nijkamp FP, Folkerts G. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res 2006, 7:66. 10.1186/1465-9921-7-66, 1481582, 16620395.
44. Cho HY, Jedlicka AE, Clarke R, Kleeberger SR. Role of Toll-like receptor-4 in genetic susceptibility to lung injury induced by residual oil fly ash. Physiol Genomics 2005, 22:108-117. 10.1152/physiolgenomics.00037.2005, 15784698.